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The authors aimed to analyze the relationship between
subclinical renal damage, defined as the presence of
microalbuminuria or an estimated glomerular filtration rate
(eGFR) between 30 mL/min/1.73 m2 and 60 mL/min/
1.73 m2 and short-term blood pressure (BP) variability,
assessed as average real variability (ARV), weighted stan-
dard deviation (SD) of 24-hour BP, and SD of daytime and
nighttime BP. A total of 328 hypertensive patients underwent
24-hour ambulatory BP monitoring, 24-hour albumin excre-
tion rate determination, and eGFR calculation using the
Chronic Kidney Disease Epidemiology Collaboration
equation. ARV of 24-hour systolic BP (SBP) was significantly
higher in patients with subclinical renal damage (P=.001).
This association held (P=.04) after adjustment for potential
confounders. In patients with microalbuminuria, ARV of 24-
hour SBP, weighted SD of 24-hour SBP, and SD of daytime
SBP were also independently and inversely related to eGFR.
These results seem to suggest that in essential hyperten-
sion, short-term BP variability is independently associated
with early renal abnormalities. J Clin Hypertens (Greenwich).
2015;17:473–480. ª 2015 Wiley Periodicals, Inc.
Since the pioneering observations of Stephen Hales
during the 18th century it has been recognized that
blood pressure (BP) is not a constant parameter; rather,
it shows marked spontaneous oscillations over short-
term (minutes to hours) and long-term (days to months)
periods. Far from being a “background noise” that
hindered assessment of “true BP,” short-term BP vari-
ability (BPV) seems to be relevant to the pathophysiol-
ogy of target organ damage and to the incidence of
clinical events, as suggested by studies performed in
humans by invasive continuous 24-hour BP measure-
ments1,2 and as clearly shown by investigations con-
ducted in sinoaortic-denervated rats.3–6 Although the
precise quantification of short-term BPV requires beat-
to-beat BP recording,7 its assessment is also possible,
even if less accurately, through the use of intermittent
noninvasive 24-hour ambulatory BP monitoring
(ABPM). However, studies in which short-term BPV
was estimated by ABPM yielded conflicting results.8–32
Short-term BP variability has been usually estimated
by 24-hour, daytime, or nighttime standard deviation
(SD) of average BP. However, the limitations of the SD
as a measure of short-term BPV have stimulated the
search of more refined BPV estimates.6,7,10,13,20,21
One of these is the average real variability (ARV) of
24-hour BP, ie, the average of the absolute differences of
consecutive measurements.20 This statistical parameter
is sensitive to the individual BP measurement order and
less sensitive to low sampling frequency of ABPM.21
Some studies suggest that ARV better predicts cardio-
vascular (CV) risk in comparison to the traditional SD.
20,22,23
Another new index of short-term BPV is the
“weighted” SD of the 24-hour mean value, ie, the
average SD of daytime and nighttime BP, each weighted
for the duration of the day and night periods, respec-
tively. This in order to mathematically remove any
potential interference of the magnitude of the day-night
BP difference, regarded as a “beneficial” component of
24-hour BP variability from the quantification of overall
24-hour SD.10
Chronic kidney disease (CKD), since the earliest
stages, is associated with a high risk of premature CV
events.33,34 It could be hypothesized that an enhanced
short-term BPV in patients with early renal abnormal-
ities may help to explain in part their increased CV risk.
Only a few studies explored the relationship between
short-term BPV and markers of early renal damage,
with conflicting results.11–13,29,30 In particular, little is
known about the association of early renal abnormal-
ities with ARV of 24-hour BP and with weighted SD
(wSD) of 24-hour BP.30
Our study aimed to analyze, in a group of untreated
essential hypertensive (EH) patients, the relationship
between subclinical renal damage and short-term BPV.
METHODS
The study population was selected from the hyperten-
sive patients consecutively attending our hypertension
center. Most of them had been referred to our
institution by their general practitioners for specialist
advice.
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ORIGINAL PAPER
Exclusion criteria were age younger than 18 years
and older than 70 years; renovascular, malignant,
endocrine hypertension, or hypertension associated with
obstructive sleep apnea syndrome; known proteinuria
and hematuria; estimated GFR (eGFR) <30 mL/min/
1.73 m2; previous known nephritic diseases and hered-
itary renal diseases; heart failure; history or clinical
signs of ischemic heart disease or cerebrovascular
diseases; major non-CV diseases; and unreliable 24-
hour urine collection
Endocrine and renovascular hypertension were ruled
out, as previously described.35,36 Persons who reported
smoking cigarettes regularly during the past year were
considered current smokers.
Written informed consent was obtained from each
patient. The study protocol conformed to the ethical
guidelines of the Declaration of Helsinki and was
approved by the local review board.
Study Design
In all patients, careful clinical history and physical
examination were performed. Furthermore, 24-hour
ABPM was carried out. Additionally, a 24-hour urine
sample was collected to evaluate albumin excretion rate
(AER).
Measurements
The 24-hour AER was assayed by a solid-phase enzyme
immunoassay (Microalbumin-ELISA; DRG Diagnos-
tics, Marburg, Germany). Further details about the
assay characteristics and the precautions taken for the
urine collection procedures are reported elsewhere.36
Microalbuminuria was defined as an AER of 20 lg/min
to 200 lg/min, which is equivalent to a range of 30 mg/
d to 300 mg/d.34
Creatinine was measured using the Creatinine Plus
standardized enzymatic assay (Roche Diagnostics).
eGFR was calculated using the Chronic Kidney Disease
Epidemiology Collaboration (CKD-EPI) equation.37
In line with the 2013 European Society of Hyperten-
sion/European Society of Cardiology guidelines for the
management of arterial hypertension,38 subclinical
(asymptomatic) renal organ damage was defined by
the presence of microalbuminuria or eGFR between
30 mL/min/1.73 m2 and 60 mL/min/1.73 m2.
A portable, noninvasive SpaceLabs 90207 recorder
(Redmond, WA) was used to perform 24-hour ABPM.
BP was recorded automatically at 15-minute intervals
during the day and at 20-minute intervals during
nighttime resting. Only records with more than 80%
of valid data were accepted. Moreover, ABPM with no
consecutive hours without valid readings and ≤3 hours
without valid readings were also discarded. If the
patient agreed, in case of poor-quality recordings,
ABPM was repeated within 1 week of the first evalu-
ation. Further details regarding the procedures for
ABPM were published previously.35,36
Short-term BPV was estimated with the following
parameters: (1) SD of daytime (systolic and diastolic)
BP; (2) SD of nighttime BP; (3) wSD 24-hour BP, defined
as the mean of daytime and nighttime BP SD weighted
by the duration (in number of hours) of each time
period10; and (4) average real variability of 24-hour BP,
calculated using the following formula:
ARV ¼ 1
N  1
XN1
k¼1
jBPkþ1  BPkj
where k ranges from 1 to n1, and n is the number of
BP readings.20
Statistics
Normal distribution of the continuous variables was
assessed by the Kolmogorov-Smirnov test and the
assumption of satisfactory Gaussian distribution was
not met for the following variables: AER, triglycerides,
and all the indices of short-term BPV evaluated in the
present study. They were expressed as median and
interquartile range and transformed to natural loga-
rithm to better satisfy distributional assumptions before
parametric tests were used.
Differences between groups were evaluated using the
independent-sample Student t test for continuous vari-
ables and the chi-square test for the categorical vari-
ables. Adjustment for potential confounding factors was
carried out by analysis of covariance (ANCOVA).
Univariate associations between the indices of short-
term BPV, AER, eGFR, and other variables were
assessed by simple linear regression analyses and Pear-
son correlation coefficients.
To investigate the multivariate association of short-
term BPV with preclinical renal damage, multiple
stepwise logistic regression analyses were performed
by calculating odds ratios (ORs) and their 95% confi-
dence limits on the basis of various models in which the
presence or absence of renal damage was considered as a
dependent variable and each index of short-term BPV
(separately included) regarded as explanatory variable
along with the corresponding average BP value, age,
sex, diabetes, and waist circumference.
Multiple linear regression analyses were also used to
evaluate the independent correlates of (log) AER and
eGFR, including the indices of short-term BPV (sepa-
rately from each other) into the models as explanatory
variables and all the parameters associated with the
markers of renal dysfunction and with the indices of
short-term BPV in univariate analyses. The potential
influence of microalbuminuria on the relationship
between short-term BPV and eGFR was tested by also
including into the multivariate models the multiplicative
two-way interaction term index of short-term
BPV 9 microalbuminuria. The null hypothesis was
rejected at a two-tailed P<.05.
Statistical analyses were performed using the SYSTAT
DATA software package, version 12 (Systat, San Jose,
CA).
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RESULTS
We enrolled 328 untreated essential hypertensive
patients. Of these, 309 (94%) had never been treated
for hypertension, whereas 19 (6%) had received anti-
hypertensive treatment in the past but not during the
3 months before the study.
No sign of renal dysfunction was detected in 232
patients, while the remaining 96 patients were consid-
ered to have subclinical renal damage. Eighteen patients
had an eGFR ≤60 mL/min/1.73 m2 and 93 had micro-
albuminuria. Table I presents the clinical and demo-
graphic characteristics of the patients.
Body mass index (BMI), waist circumference, (log)
serum triglycerides, serum uric acid (serum uric acid),
and (log) AER and the proportion of patients with type
2 diabetes were significantly higher and the eGFR lower
in the group with subclinical renal damage than in those
without renal dysfunction. High-density lipoprotein
cholesterol tended to be lower and the percentage of
men tended to be greater in the former group when
compared with the latter, albeit these differences did not
attain statistical significance.
As shown in Table II, the patients with subclinical
renal damage exhibited higher values of clinic, 24-hour,
daytime, and nighttime systolic BP (SBP), as well as of
24-hour diastolic BP (DBP), in comparison to those with
normal kidney function.
The two groups did not differ with respect to the
indices of short-term BPV (Table II), except for ARV
of 24-hour SBP (9.9 [8.6–11.2] mm Hg vs 9.1 [8–
10.2] mm Hg; P=.001) (Figure 1) and ARV of 24-hour
DBP (8 [7–9.6] mm Hg vs 7.5 [6.9–8.9] mm Hg;
P=.03), which were higher in patients with subclinical
renal damage. The difference regarding ARV of 24-
hour SBP, but not that regarding ARV of 24-hour
DBP, held (P=.02) even after adjustment by ANCOVA
for age, sex, 24-hour mean SBP, waist circumference,
serum uric acid, and diabetic status. All the indices of
short-term BPV were not significantly different
between smokers and nonsmokers (all P>.12; data
not shown).
The correlation between short-term BPV indices and
markers of subclinical renal damage with each other and
with other variables in the whole population are shown
in Table III.
eGFR was significantly related in an inverse manner
to SD of daytime SBP, wSD of 24-hour SBP, and ARV of
24-hour SBP. These relationships were driven by the
close correlations observed between these variables in
the subset of patients with microalbuminuria, whereas
there was no significant correlation in those without
microalbuminuria (Figures 2–4). The other significant
univariate correlates of eGFR in the overall population
were age, (log) AER, serum uric acid, serum glucose,
total cholesterol, BMI, waist circumference, and clinic,
24-hour, and nighttime SBP. Among the indices of
short-term BPV, only ARV of 24-hour SBP was signif-
icantly related to (log) AER, whereas the relationships
of AER with SD of daytime SBP and with wSD of 24-
hour SBP did not reach statistical significance (P=.096
and P=.093, respectively). Albumin excretion rate was
also positively associated with serum uric acid, BMI,
waist circumference, (log) triglycerides, clinic SBP, and
24-hour, daytime, and nighttime SBP and DBP and
inversely associated with HDL cholesterol.
The logistic multiple regression analysis revealed that
the presence of subclinical renal damage was indepen-
dently associated with (log) ARV of 24-hour systolic BP
(OR per unit increase, 4.2 [1.07–15.8]; P=.04), along
with 24-hour mean SBP (OR per 1-mm Hg increase,
1.03 [1.01–1.05]; P=.02), waist circumference (OR per
1-cm increase, 1.04 [1.01–1.07; P=.004]), serum uric
acid (OR per 1-mg/dL increase, 1.4 [1.13–1.75];
P=.003), and diabetes (yes=1; no=0; OR, 2.16 [1.08–
4.3]; P=.03). When the ARVs of 24-hour SBP and DBP
were replaced by wSD of 24-hour SBP and DBP in the
same model, neither the former nor the latter were
related to subclinical renal damage. Similarly, SD of
TABLE I. Clinical and Demographic Characteristics of Hypertensive Patients With Subclinical Renal Damage and
Without Kidney Damage
Subclinical Renal Damage (n=96) No Kidney Damage (n=232) P Value
Age, y 47.014.0 45.711.9 .394
Men, No. (%) 63 (65.6) 129 (55.6) .086
Smokers, No.(%) 31 (32.3) 66 (28.4) .429
Type 2 diabetes, No. (%) 18 (18.8) 23 (9.9) .02
Serum glucose, mg/dL 97.022.1 95.621.1 .590
Body mass index, kg/m2 28.84.8 27.33.9 .003
Waist circumference, cm 98.612.5 92.911.0 <.001
Total cholesterol, mg/dL 206.542.0 212.840.4 .205
HDL cholesterol, mg/dL 45.811.1 48.210.2 .059
Serum triglycerides, mg/dL 136.0 (93.0–193.0) 118.5 (78.5–160.5) .008
Serum uric acid, mg/dL 5.71.7 4.81.3 <.001
Albumin excretion rate, lg/min 37.7 (27.0–123.9) 7.2 (4.6–12.1) <.001
Estimated GFR, mL/min/1.73 m2 89.415.5 99.515.3 <.001
Abbreviations: GFR, glomerular filtration rate; HDL, high-density lipoprotein.
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daytime SBP and DBP and SD of nighttime SBP and
DBP were independently associated with subclinical
renal damage when included in the multivariate model
in lieu of ARV of 24-hour SBP and DBP, along with
the corresponding daytime or nighttime mean BP
values. Analogous conclusions were reached when the
mean values of ambulatory BP readings were replaced
by clinic BPs; when diabetes, as a dichotomous
variable, was replaced by serum glucose; or when
BMI was introduced into the model instead of waist
circumference.
When we explored the independent correlates of
eGFR by a stepwise linear multiple regression analysis,
we found that none of the indices of short-term BPV
were related to the outcome variable. However, along
with age (b=0.59; P<.001) and serum uric acid
(b=0.17; P=.002), the interaction term ARV of 24-
hour SBP 9 microalbuminuria was inversely associ-
ated with eGFR (b=0.21; P<.001). Similar results
were obtained when the interaction term ARV of 24-
hour SBP 9 microalbuminuria was replaced in the
multivariate model by the term wSD of 24-hour
SBP 9 microalbuminuria (b=0.19; P<.001) or by
the term SD of daytime SBP 9 microalbuminuria
(b=0.20; P<.001).
When we repeated multiple regression analysis con-
sidering (log) AER as the outcome variable, we observed
that serum glucose (b=0.15; P=.04), serum uric acid
(b=0.16; P=.01), waist circumference (b=0.16; P=.015),
eGFR (b=0.17; P=.01), 24-hour mean SBP (b=.17;
P=.004), and ARV of 24-hour SBP (b=0.14; P=.03) were
independently associated with AER. When the other
indices of short-term BPV replaced ARV of 24-hour SBP
in the multivariate model, none of these indices showed
a significant relationship with (log) AER.
DISCUSSION
The main finding of our study was the identification of a
significant association between the combination of early
renal abnormalities configuring subclinical renal dam-
age and the ARV of 24-hour SBP in a cohort of
untreated hypertensive patients. This association was
weakened but still significant after adjustment for
potential confounding factors such as age and average
level of 24-hour SBP. It was driven chiefly by the
positive relationship we also observed between ARV of
24-hour SBP and AER. In contrast, inverse associati-
ons between eGFR with ARV of 24-hour SBP, wSD of
TABLE II. Clinic and Ambulatory BP Data of Hypertensive Patients With Subclinical Renal Damage and Without
Kidney Damage
Subclinical Renal Damage (n=96) No Kidney Damage (n=232) P Value
Clinic systolic BP, mm Hg 15720 15217 .022
Clinic diastolic BP, mm Hg 9819 9516 .145
24-h systolic BP, mm Hg 14012 13412 <.0001
24-h diastolic BP, mm Hg 8811 8510 .017
24-h heart rate, beats per min 7410 749 .985
Daytime systolic BP, mm Hg 14412 13812 <.0001
Daytime diastolic, mm Hg 9111 8910 .111
Nighttime systolic BP, mm Hg 13115 12513 <.0001
Nighttime diastolic BP, mm Hg 8111 808 .359
SD of daytime systolic BP, mm Hg 12.4 (9.7–14.8) 11.9 (9.7–14.1) .489
SD of daytime diastolic BP, mm Hg 10.4 (8.2–12.9) 10.2 (8.8–12.3) .928
SD of nighttime systolic BP, mm Hg 12.1 (9.4–15.1) 11.9 (9.7–14.3) .589
SD of nighttime diastolic BP, mm Hg 10.8 (8.6–13.1) 10.8 (9.0–12.8) .710
Weighted SD of 24-h systolic BP, mm Hg 12.2 (10.2–14.2) 11.5 (9.7–14.4) .597
Weighted SD of 24-h diastolic BP, mm Hg 11.1 (9.3–12.9) 10.8 (9.1–12.0) .190
Abbreviations: BP, blood pressure; SD, standard deviation.
FIGURE 1. Box plots showing average real variability of 24-hours
systolic blood pressure in hypertensive patients with subclinical
renal damage and in those without it. In the box-and-whisker plots,
the central boxes represent the values from the lower to upper
quartile (25–75 percentile). The middle lines represent the medians.
Lower and upper whiskers extend to 5th and 95th percentiles. This
difference remained significant (P=.02), even after adjustment by
analysis of covariance for age, sex, 24-hour mean systolic BP, waist
circumference, serum uric acid, and diabetic status.
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24-hour SBP, and SD of daytime SBP were observed
only in univariate analyses carried out in the overall
study population, but they lost statistical significance
after taking into account the effect of some covariates in
multiple regression analyses. These relationships again
became significant in the presence of microalbuminuria.
Indeed, when the interaction terms ARV of 24-hour
SBP 9 microalbuminuria, wSD of 24-hour SBP 9 mi-
croalbuminuria, and SD of daytime SBP 9 microalbu-
TABLE III. Correlations of Short-Term BP Variability Indices and Renal Parameters With Each Other and With Other
Variables in the Whole Study Population
eGFR (Log) AER
SD of Daytime BP SD of Nighttime BP
Weighted SD of 24-H
BP ARV of 24-Hours BP
Systolic Diastolic Systolic Diastolic Systolic Diastolic Systolic Diastolic
r r r r r r r r r r
Estimated GFR – 0.168a 0.124b 0.019 0.090 0.067 0.140b 0.05 0.145e 0.027
(Log) AER 0.168a – 0.092 0.033 0.066 0.049 0.093 0.020 0.169a 0.090
Serum uric acid 0.175c 0.268d 0.020 0.050 0.034 0.086 0.034 0.088 0.101 0.005
Age 0.596d 0.033 0.299d 0.079 0.135b 0.017 0.296d 0.049 0.302d 0.016
Body mass index 0.225d 0.150e 0.112b 0.139b 0.131b 0.048 0.163a 0.110b 0.169a 0.183c
Waist
circumference
0.187c 0.190c 0.049 0.093 0.109b 0.040 0.101 0.063 0.122b 0.115b
Glycemia 0.123b 0.127b 0.044 0.087 0.053 0.044 0.093 0.110b 0.037 0.024
Total cholesterol 0.183c 0.005 0.123b 0.074 0.005 0.014 0.105 0.088 0.056 0.016
HDL cholesterol 0.089 0111b 0.001 0.061 0.124b 0.136b 0.043 0.087 0.003 0.048
(Log) triglycerides 0.100 0.126b 0.081 0.104 0.087 0.131b 0.157a 0.141b 0.005 0.001
Clinic systolic BP 0.206f 0.133b 0.250d 0.244d 0.137b 0.136b 0.257d 0.247d 0.103 0.094
Clinic diastolic BP 0.007 0.087 0.083 0.161a 0.137b 0.136b 0.078 0.171a 0.057 0.061
24-h systolic BP 0.113b 0.226d 0.183c 0.136b 0.222d 0.157a 0.216d 0.141b 0.264d 0.118b
24-h diastolic BP 0.035 0.134b 0.039 0.031 0.035 0.062 0.067 0.021 0.050 0.030
Daytime systolic BP 0.042 0.215d 0.229d 0.153e 0.204f 0.164a 0.217d 0.151e 0.270d 0.109b
Daytime diastolic BP 0.049 0.118b 0.018 0.014 0.016 0.102 0.012 0.018 0.030 0.069
Nighttime systolic BP 0.163a 0.184c 0.163a 0.105 0.123b 0.060 0.146e 0.071 0.212f 0.095
Nighttime
diastolic BP
0.005 0.121b 0.046 0.074 0.023 0.001 0.104 0.082 0.042 0.060
Abbreviations: AER, albumin excretion rate; BP, blood pressure; GFR, glomerular filtration rate; HDL, high-density lipoprotein; SD, standard deviation.
aP<.005. bP<.05. cP<.001. dP<.0001. eP<.01. fP<.0005.
FIGURE 2. Scattergram showing the relationship between average
real variability of 24-hours systolic blood pressure (transformed as a
logarithm for its skewed distribution) and estimated glomerular
filtration rate in hypertensive patients with microalbuminuria (filled
squares) and without microalbuminuria (open circles). The
calculated regression lines for microalbuminuric (solid line) and
normoalbuminuric (broken line) subjects are also shown.
FIGURE 3. Scattergram showing the relationship between
weighted standard deviation (SD) of 24-hours systolic blood
pressure (transformed as a logarithm for its skewed distribution) and
estimated glomerular filtration rate in hypertensive patients with
microalbuminuria (filled squares) and without microalbuminuria
(open circles). The calculated regression lines for microalbuminuric
(solid line) and normoalbuminuric (broken line) subjects are also
shown.
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minuria were included alternatively into the multiple
regression models with the outcome variable eGFR, all
the corresponding P values were <.001.
Limited and conflicting data exist regarding the
relationship between short-term BPV and early markers
of kidney damage.11–13,29,30 Several hypotheses can be
offered to explain discrepant conclusions of these
studies, including the present investigation. One puta-
tive reason may be the different number of valid BP
readings or the difference in the interval of BP record-
ings during which short-term BPV was assessed, which
was generally shorter in our study (every 15 minutes
during daytime and every 20 minutes during nighttime)
when compared with other studies. It is well-known that
the accuracy of the estimates of short-term BPV,
obtained by intermittent recordings, is heavily depen-
dent on the frequency and/or number of BP readings.39
Other potential reasons for inconsistent findings may
be the different methods used to assess short-term BPV
and measure AER as well as the wide variability in
microalbuminuria assay.
To the best of our knowledge, the present study was
the first to evaluate the relationship of ARV and wSD of
24-hour BP with AER and eGFR in the same partici-
pants. Manios and colleagues13 addressed the relation-
ship between a novel index of short-term BPV, the rate
of 24-hour BP variation, and GFR estimated by the
abbreviated MDRD study equation in 803 untreated
hypertensive patients. This parameter, which is the first
derivative of BP values against time and therefore a
measure of the speed of BP fluctuations, is similar to
ARV.13,40 It was higher in patients with eGFR <60 mL/
min/1.73 m2 than in those with greater value of
eGFR.13 However, our study presents many different
findings compared with those of Manios and colleagues.
In this study, eGFR was not used as a continuous
variable because the MDRD formula has not been
validated for eGFRs >60 mL/min per 1.73m2. In con-
trast, we used the eGFR with CKD-EPI equation, which
is more accurate than the MDRD formula, when the
GFR is >60 mL/min per 1.73m2.37 By using the CKD-
EPI equation it is possible to report eGFR across the
entire range of values without substantial bias. Further-
more, the patients enrolled in our study were about
9 years younger than those in the study by Manios and
colleagues.13
Unlike the study by Manios and associates, we found
no independent association with any of the indices of
short-term BPV and the eGFR in the overall population,
even though the negative relationship between short-
term BPV and eGFR became strongly significant in
microalbuminuric patients. A putative explanation of
our finding may be that microalbuminuria interacts
synergistically with an increased short-term SBP to
impair the glomerular filtration process. In other words,
an enhanced short-term BPV may adversely affect the
glomerular filtration only in the presence of a sign of
early kidney injury, such as microalbuminuria, which
may be an expression of impaired autoregulation of
glomerular blood flow.34 It may be assumed that when
autoregulation is disturbed the glomerular vascular bed
may become more vulnerable to the mechanical insults
derived from wide BP fluctuations.
For the cross-sectional nature of the present study this
explanation remains speculative and needs to be tested
in future investigations. Similarly, it is important to
recognize that the association between short-term BPV
and microalbuminuria do not imply causality and it is
possible that short-term BPV elevation may be the
product, rather than the cause, of early renal damage.
It is entirely possible that heightened short-term BPV,
from whatever cause, leads to renal damage by afferent
arteriolar barotraumas. It is also conceivable that the
relationship between short-term BPV and AER is not
direct but is mediated by an increased large artery
stiffness, resulting from the traumatic effect of wider BP
swings on the walls of conduit arteries. This, in turn,
may determine increased urinary excretion of albumin.
In this regard, it is interesting to note that in
sinoaortic-denervated rats, an experimental model of
high short-term BPV without hypertension, Miao and
Su demonstrated that a chronic increase in BPV
produces aortic hypertrophy after 2 weeks of the
surgical intervention and left ventricular hypertrophy
after at least 10 weeks. In contrast, histological kidney
damage was evident after only 16 weeks.4,5 This lends
support to the view that aortic hypertrophy induced by
enhanced BPV may lead to an impaired arterial disten-
sibility, thereby increasing left ventricular load and, in
turn, favoring left ventricular hypertrophy and subse-
quently renal damage.
However, it is also entirely possible that aortic
stiffness, which is closely associated with microalbu-
minuria, may induce wider fluctuations in SBP. This is
FIGURE 4. Scattergram showing the relationship between
standard deviation (SD) of daytime systolic blood pressure
(transformed as a logarithm for its skewed distribution) and
estimated glomerular filtration rate in hypertensive patients with
microalbuminuria (filled squares) and without microalbuminuria
(open circles). The calculated regression lines for microalbuminuric
(solid line) and normoalbuminuric (broken line) subjects are also
shown.
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because rigid carotid and aortic walls determine a
reduced stimulation of arterial baroreceptors located in
these vascular areas by pulsatile BP, with a consequent
impaired sensitivity of the baroreflex and its resulting
reduced ability in buffering BP oscillations. Therefore,
microalbuminuria could simply represent an epiphe-
nomenon of arterial stiffness and systemic endothelial
dysfunction, without a causative pathogenetic role in
this context.
It is noteworthy that a close association between
short-term BPV and aortic stiffness has been docu-
mented by Schillaci and colleagues.14 In this investiga-
tion, the relationship between aortic PWV and ARV of
24-hour SBP (the only index of short-term BPV associ-
ated with microalbuminuria in our study) was stronger
than that with SD of 24-hour, daytime, or nighttime
SBP.14
It is also worth noting that our results were obtained
in a select population of untreated young and middle-
aged Caucasian patients with mild to moderate essential
hypertension, without severe renal functional impair-
ment and free of CV diseases. Therefore, the conclusions
of our study cannot be extrapolated to non-white
populations and caution is needed when applying the
results of our investigation to treated hypertensive
patients or to those with more advanced degrees of
kidney or CV damage.
CONCLUSIONS
Our study showed an independent, albeit modest,
association between early renal abnormalities and some
indices of short-term BPV in untreated patients with
essential hypertension. This may help to explain the
elevated CV risk associated with enhanced short-term
blood pressure (STBP) variability and with both micro-
albuminuria and mild to moderate reduction in GFR.
Further longitudinal studies are needed to understand
the causal link between increased short-term BPV and
subclinical renal damage. Future studies are also needed
to determine whether medications able to reduce short-
term BPV would be of clinical benefit in the prevention
or treatment of early renal damage.
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